If you are running a serious body-composition protocol in the UAE in 2026, REVIVE LAB UAE is where the work begins. Researchers in Dubai, Abu Dhabi and Sharjah keep returning to one specific pairing on our order sheets: tesamorelin layered with MOTS-c. The logic is clean — one peptide rewires the growth hormone axis from above, the other rewires mitochondrial substrate selection from below. The result, in published literature and in protocol logs, is a stack that does what monotherapy alone keeps undershooting on: visceral adipose tissue reduction without the lean-mass concession.
You can buy tesamorelin 5mg or 10mg in Dubai from REVIVE LAB UAE today and have it delivered same-day across the emirate. This post breaks down why the stack works, the protocol parameters UAE researchers are running, and how to source both peptides — research grade, HPLC-tested — from a UAE peptides supplier that actually keeps cold chain intact.
Tesamorelin is a 44-amino-acid GHRH analog. In the Stanley 2014 lipodystrophy trial (and the earlier Falutz 2007 and Falutz 2010 NEJM and JCEM papers), tesamorelin demonstrated a roughly 15–18% reduction in visceral adipose tissue (VAT) over 26 weeks at 2 mg subcutaneous daily — without altering subcutaneous fat in a meaningful way, and crucially without the lean-mass loss seen in GLP-1 monotherapy.
The mechanism is upstream and endocrine: tesamorelin binds the GHRH receptor on the anterior pituitary, restoring pulsatile GH secretion, lifting IGF-1, and producing a lipolytic signal that preferentially mobilises visceral fat. That is the GH axis.
But here is where solo tesamorelin protocols plateau. Lipolysis liberates free fatty acids. Whether those fatty acids actually get oxidised — or simply re-esterified back into triglyceride — depends on what is happening inside the mitochondria. If mitochondrial substrate utilisation is sluggish, you free the fat and then watch it park itself again. That is the substrate-layer problem, and that is the gap MOTS-c fills.
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA. Lee 2015 (Cell Metabolism) showed MOTS-c activates AMPK, increases glucose uptake, promotes fatty acid β-oxidation, and improves insulin sensitivity in skeletal muscle. Reynolds 2021 expanded the exercise-mimetic profile in human muscle biopsy data.
So while tesamorelin is at the pituitary saying "release the fat," MOTS-c is at the mitochondrial membrane saying "burn it now." This is the stack thesis. Two layers, two peptides, two mechanisms — convergent endpoint.
| Parameter | Tesamorelin (5mg / 10mg) | MOTS-c (10mg) |
|---|---|---|
| Class | GHRH analog | Mitochondrial-derived peptide |
| Site of action | Pituitary (endocrine) | Mitochondria (substrate) |
| Key pathway | GH / IGF-1 axis | AMPK / fatty acid oxidation |
| Anchor study | Stanley 2014, Falutz 2010 | Lee 2015, Reynolds 2021 |
| Typical research dose | 1–2 mg SC daily | 5–10 mg SC weekly |
| Storage post-reconstitution | Fridge 2–8°C, 28 days | Fridge 2–8°C, 28 days |
| Stocked at REVIVE LAB UAE | 5 mg + 10 mg vials | 10 mg vials |
This is the cycle structure most commonly reported by REVIVE Peptides UAE clients running the stack out of Dubai Marina, Business Bay, Jumeirah, JBR, Palm Jumeirah and DIFC labs. Reconstitution uses BAC water 3 mL, drawn with a 1 mL insulin syringe and a 29G or 31G needle for subcutaneous administration.
One 10 mg tesamorelin vial reconstituted in 3 mL BAC water gives roughly 33 doses at 1 mg, or 16 doses at 2 mg. A 10 mg MOTS-c vial covers the 8-week window comfortably at twice-weekly 10 mg working dose.
The stack only works if the cold chain holds. Lyophilized vials are stable at room temperature for shipment, but vial integrity and reconstituted shelf life depend on a courier that does not let your peptide bake on a Dubai dashboard. REVIVE Peptides UAE uses temperature-controlled couriers across:
REVIVE LAB UAE is a UAE-based research peptides supplier operating directly out of Dubai. Every vial we ship — tesamorelin 5 mg, tesamorelin 10 mg, MOTS-c 10 mg, BAC water 3 mL — is HPLC-tested with an associated certificate of analysis available on request. We hold inventory locally so "in stock UAE" means the vial is already in our Dubai cold storage, not in a queue from overseas. Same-day Dubai dispatch, anonymous shipping, cold-chain courier, cash on delivery: that is the standard. Browse all REVIVE Peptides UAE products to see the full inventory.
If you are weighing options as a UAE researcher running a body-recomposition protocol, here is the honest contrast on the literature available today:
| Protocol | VAT reduction | Lean mass | Sleep / recovery | Stack synergy |
|---|---|---|---|---|
| GLP-1 monotherapy | Moderate | Often lost (15–40% of weight) | Neutral | Low |
| Tesamorelin alone | ~15–18% (Stanley 2014) | Preserved/improved | Improved (deep sleep) | Moderate |
| Tesamorelin + MOTS-c | Highest in protocol logs | Preserved + insulin sensitivity | Improved | High |
REVIVE LAB UAE ships tesamorelin 5 mg and 10 mg same-day across Dubai (Marina, JBR, Business Bay, DIFC, Palm Jumeirah, JVC, Mirdif, Al Barsha and beyond), and 24h to Sharjah, Ajman, RAK, Fujairah and Al Ain. Order before 3pm for same-day Dubai dispatch.
Yes. All REVIVE Peptides UAE vials are sold for research-use only under an appropriate IRB protocol or equivalent institutional framework. Not for human consumption. This article is not medical advice.
At a 2 mg working dose, a 10 mg vial reconstituted in 3 mL BAC water yields approximately 16 doses. On the 5-on-2-off protocol described above that is roughly three weeks of working-dose tesamorelin per 10 mg vial.